- Home
- ACXP vs CMBM Comparison
ACXP vs CMBM Comparison
Compare ACXP & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- CMBM
- Stock Information
- Founded
- ACXP 2017
- CMBM 2011
- Country
- ACXP United States
- CMBM United States
- Employees
- ACXP N/A
- CMBM N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- CMBM Radio And Television Broadcasting And Communications Equipment
- Sector
- ACXP Health Care
- CMBM Technology
- Exchange
- ACXP Nasdaq
- CMBM Nasdaq
- Market Cap
- ACXP 8.4M
- CMBM 9.6M
- IPO Year
- ACXP 2021
- CMBM 2019
- Fundamental
- Price
- ACXP $0.49
- CMBM $0.40
- Analyst Decision
- ACXP Strong Buy
- CMBM Strong Buy
- Analyst Count
- ACXP 2
- CMBM 2
- Target Price
- ACXP $10.00
- CMBM $5.50
- AVG Volume (30 Days)
- ACXP 18.6M
- CMBM 1.0M
- Earning Date
- ACXP 08-08-2025
- CMBM 08-07-2025
- Dividend Yield
- ACXP N/A
- CMBM N/A
- EPS Growth
- ACXP N/A
- CMBM N/A
- EPS
- ACXP N/A
- CMBM N/A
- Revenue
- ACXP N/A
- CMBM $172,215,000.00
- Revenue This Year
- ACXP N/A
- CMBM N/A
- Revenue Next Year
- ACXP N/A
- CMBM $17.87
- P/E Ratio
- ACXP N/A
- CMBM N/A
- Revenue Growth
- ACXP N/A
- CMBM N/A
- 52 Week Low
- ACXP $0.30
- CMBM $0.23
- 52 Week High
- ACXP $3.33
- CMBM $2.50
- Technical
- Relative Strength Index (RSI)
- ACXP 51.01
- CMBM 56.74
- Support Level
- ACXP $0.46
- CMBM $0.38
- Resistance Level
- ACXP $0.56
- CMBM $0.47
- Average True Range (ATR)
- ACXP 0.10
- CMBM 0.04
- MACD
- ACXP -0.01
- CMBM 0.01
- Stochastic Oscillator
- ACXP 24.27
- CMBM 70.13
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.